These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23717153)

  • 21. Pharmacological and medical applications of
    Kim JH
    J Ginseng Res; 2018 Jul; 42(3):264-269. PubMed ID: 29983607
    [No Abstract]   [Full Text] [Related]  

  • 22. Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells.
    Lee DC; Yang CL; Chik SC; Li JC; Rong JH; Chan GC; Lau AS
    J Transl Med; 2009 May; 7():34. PubMed ID: 19442267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ginseng's fireness is associated with the lowering activity of liver Na(+)-K(+)-ATPase.
    Xu X; Dou D
    J Ethnopharmacol; 2016 Aug; 190():241-50. PubMed ID: 27288755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2.
    Li CT; Wang HB; Xu BJ
    Pharm Biol; 2013 Aug; 51(8):1077-80. PubMed ID: 23742679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of ginseng in the management of cardiovascular disorders.
    Karmazyn M; Moey M; Gan XT
    Drugs; 2011 Oct; 71(15):1989-2008. PubMed ID: 21985167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Synergistic Effects of Polysaccharides and Ginsenosides From American Ginseng (
    Zhou R; He D; Xie J; Zhou Q; Zeng H; Li H; Huang L
    Front Immunol; 2021; 12():665901. PubMed ID: 33968068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
    Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginsenosides: are any of them candidates for drugs acting on the central nervous system?
    Nah SY; Kim DH; Rhim H
    CNS Drug Rev; 2007; 13(4):381-404. PubMed ID: 18078425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginsenoside Rc from Korean Red Ginseng (Panax ginseng C.A. Meyer) Attenuates Inflammatory Symptoms of Gastritis, Hepatitis and Arthritis.
    Yu T; Rhee MH; Lee J; Kim SH; Yang Y; Kim HG; Kim Y; Kim C; Kwak YS; Kim JH; Cho JY
    Am J Chin Med; 2016; 44(3):595-615. PubMed ID: 27109153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginseng as a Treatment for Fatigue: A Systematic Review.
    Arring NM; Millstine D; Marks LA; Nail LM
    J Altern Complement Med; 2018 Jul; 24(7):624-633. PubMed ID: 29624410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Role of Ginseng and Its Constituents in the Treatment of Central Nervous System Disorders.
    Rokot NT; Kairupan TS; Cheng KC; Runtuwene J; Kapantow NH; Amitani M; Morinaga A; Amitani H; Asakawa A; Inui A
    Evid Based Complement Alternat Med; 2016; 2016():2614742. PubMed ID: 27630732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginseng compounds: an update on their molecular mechanisms and medical applications.
    Lü JM; Yao Q; Chen C
    Curr Vasc Pharmacol; 2009 Jul; 7(3):293-302. PubMed ID: 19601854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginseng on Nuclear Hormone Receptors.
    Park J; Bui PTC; Song H; Kim SK; Rhee DK; Kim EY; Rhyu MR; Lee MS; Lee YJ
    Am J Chin Med; 2017; 45(6):1147-1156. PubMed ID: 28830207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of Ginseng Anti-Diabetic Studies.
    Chen W; Balan P; Popovich DG
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in Saponin Diversity of
    Piao X; Zhang H; Kang JP; Yang DU; Li Y; Pang S; Jin Y; Yang DC; Wang Y
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-ginsenoside nicotinic activity in ginseng species.
    Lewis R; Wake G; Court G; Court JA; Pickering AT; Kim YC; Perry EK
    Phytother Res; 1999 Feb; 13(1):59-64. PubMed ID: 10189953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiomodulatory and neurological effects of ginsenosides.
    Leung KW; Yung KK; Mak NK; Yue PY; Luo HB; Cheng YK; Fan TP; Yeung HW; Ng TB; Wong RN
    Curr Med Chem; 2007; 14(12):1371-80. PubMed ID: 17504218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.
    Liu H; Lu X; Hu Y; Fan X
    Pharmacol Res; 2020 Nov; 161():105263. PubMed ID: 33127555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenosides and their CNS targets.
    Radad K; Moldzio R; Rausch WD
    CNS Neurosci Ther; 2011 Dec; 17(6):761-8. PubMed ID: 21143430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Component analysis and target cell-based neuroactivity screening of Panax ginseng by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.
    Yuan J; Chen Y; Liang J; Wang CZ; Liu X; Yan Z; Tang Y; Li J; Yuan CS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():1-11. PubMed ID: 27776327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.